Literature DB >> 9655746

Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma.

H W de Gouw1, J Hendriks, A M Woltman, I M Twiss, P J Sterk.   

Abstract

Exhaled NO is increased in patients with asthma and may reflect disease severity. We examined whether the level of exhaled NO is related to the degree of airway obstruction induced by direct and indirect stimuli in asthma. Therefore, we measured exhaled NO levels before and during recovery from histamine and hypertonic saline (HS) challenge (Protocol 1) or histamine, adenosine 5'-monophosphate (AMP), and isotonic saline (IS) challenge (Protocol 2) in 11 and in nine patients with mild to moderate asthma, respectively. The challenges were randomized with a 2-d interval. Exhaled NO and FEV1 were measured before and at 4, 10, 20, and 30 min after each challenge. NO was measured during a slow VC maneuver with a constant expiratory flow of (0.05 x FVC)/s against a resistance of 1 to 2 cm H2O. Baseline exhaled NO levels were not significantly different between study days in Protocol 1 (mean +/- SD: 4.8 +/- 1.8 ppb [histamine] versus 5.4 +/- 2.1 ppb [HS], p = 0.4) or in Protocol 2 (7.9 +/- 4.7 ppb [histamine], 8.3 +/- 5.2 ppb [AMP], and 7.2 +/- 3.7 ppb [IS], p = 0.7). A significant reduction in exhaled NO was observed directly after HS (mean +/- SEM: 39.2 +/- 3.9 %fall) and AMP challenge (32.3 +/- 7.3 %fall) (MANOVA, p < 0.001), respectively, whereas exhaled NO levels tended to decrease after histamine challenge. Isotonic saline challenge did not induce changes in exhaled NO (p = 0.7). There was a positive correlation between %fall in FEV1 and the %fall in exhaled NO after histamine, HS, and AMP challenge as indicated by the mean slope of the within-subject regression lines (p <= 0.04). We conclude that acute bronchoconstriction, as induced by direct and indirect stimuli, is associated with a reduction in exhaled NO levels in asthmatic subjects. This suggests that airway caliber should be taken into account when monitoring exhaled NO in asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655746     DOI: 10.1164/ajrccm.158.1.9703005

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma.

Authors:  M Silvestri; D Spallarossa; E Battistini; V Brusasco; G A Rossi
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Exhaled nitric oxide levels during treatment of pediatric acute asthma exacerbations and association with the need for hospitalization.

Authors:  Kyle A Nelson; Pearlene Lee; Kathryn Trinkaus; Robert C Strunk
Journal:  Pediatr Emerg Care       Date:  2011-04       Impact factor: 1.454

3.  Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breath.

Authors:  A Mashir; K M Paschke; D van Duin; N K Shrestha; D Laskowski; M K Storer; B Yen-Lieberman; S M Gordon; M Aytekin; R A Dweik
Journal:  J Breath Res       Date:  2011-07-15       Impact factor: 3.262

4.  Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.

Authors:  Alain Michils; Amaryllis Haccuria; Sebastien Michiels; Alain Van Muylem
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

5.  Effect of nebulised L- and D-arginine on exhaled nitric oxide in steroid naive asthma.

Authors:  D C Chambers; J G Ayres
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

6.  Ability of Exhaled Nitric Oxide to Discriminate for Airflow Obstruction Among Frequent Exacerbators of Clinically Diagnosed Asthma.

Authors:  Leena Jalota; D Richard Allison; Vinisha Prajapati; Jose J Vempilly; Vipul V Jain
Journal:  Lung       Date:  2018-06-18       Impact factor: 2.584

7.  Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma.

Authors:  F L M Ricciardolo; M C Timmers; J K Sont; G Folkerts; P J Sterk
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  Small airways function and molecular markers in exhaled air in mild asthma.

Authors:  S Battaglia; H den Hertog; M C Timmers; S P G Lazeroms; A M Vignola; K F Rabe; V Bellia; P S Hiemstra; P J Sterk
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 9.  The clinical significance of exhaled nitric oxide in asthma.

Authors:  Sachin Pendharkar; Sanjay Mehta
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

10.  Exhaled nitric oxide in diagnosis and management of respiratory diseases.

Authors:  Abdullah A Abba
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.